Use of horizontal ultrathin gel electrophoresis to analyze allelic deletions in chromosome band 11p15.5 in gliomas

Neuro-Oncology

Volumn 2, Issue 1, 2000, Pages 1-5

  Newsham, Irene F ^a   Gorse, Karen M ^a   Rempel, Sandra A ^b   Luckey, John ^c   Golden, James B ^c   Bögler, Oliver ^a,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HEALTH SCIENCES CENTER   (United States)

^c GeneSys Technologies Inc   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

ALLELE; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHROMOSOME 11; GENE DELETION; GENETICS; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ALLELES; ASTROCYTOMA; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 11; DNA FRAGMENTATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE DELETION; GLIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY;

EID: 0033761156     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1093/neuonc/2.1.1     Document Type: Article

References (18)

1. Baffa, R., Negrini, M., Mandes, B., Rugge, M., Ranzini, G.N., Hirohaski, S., and Croce, C.M. (1996) Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 56, 268-272.
2. Bello, M.J., Vaquero, J., de Campos, J.M., Kusak, M.E., Sarasa, J.L., Saez-Castresana, J., Pestana, A., and Rey, J.A. (1994) Molecular analysis of chromosome 1 abnormalities in human glioma reveals frequent loss of 1p in oligodendroglial tumors. Int. J. Cancer 57, 172-175.
3. Bögler, O., Huang, H.-J.S., Kleihues, P., and Cavenee, W.K. (1995) The p53 gene and its role in human brain tumors. Glia 15, 308-327.
4. Cawkwell, L., Bell, S.M., Lewis, F.A., Dixon, M.F., Taylor, G.R., and Quirke, P. (1993) Rapid detection of allele loss in colorectal tumours using microsatellite and fluorescent DNA technology. Br. J. Cancer 67, 1262-1267.
5. Fults, D., Petronio, J., Noblett, B.D., and Pedone, C.A. (1992) Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors. Genomics 14, 799-801.
6. Fumari, F.B., Huang, H.-J.S., and Cavenee, W.K. (1995) Genetics and malignant progression of human brain tumours. Cancer Surv. 25, 233-275.
7. Karnik, P., Paris, M., Williams, B.R., Casey, G., Crowe, J., and Chen, P. (1998) Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. Hum. Mol. Genet. 7, 895-903.
8. Kleihues, P., Burger, P.C., and Scheitnauer, B.W. (1993) The new WHO classification of brain tumours. Brain Pathol. 3, 255-268.
9. Kraus, J.A., Koopmann, J., Kaskel, P., Maintz, D., Brandner, S., Schramm, J., Louis, D.N., Wiestler, O.D., and von Deimling, A. (1995) Shared allelic losses on chromsomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J. Neuropath. Exp. Neurol. 54, 91-95.
10. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Pue, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella, B.C., Ittman, M., Tycko, B., Hibshoosh, H., Wigler, M.H., and Parsons, R. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947.
11. Shaw, M., and Knowles, M. (1995) Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes Cancer 13, 1-8.
12. Sonoda, Y., Lizuka, M., Yasuda, J., Makino, R., Ono, T., Kayama, T., Yoshimoto, T., and Sekiya, T. (1995) Loss of heterozygosity at 11p15 in malignant glioma. Cancer Res. 55, 2166-2168.
13. Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K.A., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D.H.F., and Tavtigian, S.V. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 15, 356-362.
14. Tran, Y.K., and Newsham, I.F. (1996) High density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. Cancer Res. 56, 2916-2921.
15. Tran, Y., Benbatoul, K., Gorse, K., Rempel, S., Futreal, A., Green, M., and Newsham, I. (1998) Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Oncogene 17, 3499-3505.
16. Viel, A., Giannini, F., Tumiotto, L., Sopracordevole, F., Visentin, M.C., and Boiochhi, M. (1992) Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. Br. J. Cancer 66, 1030-1036.
17. von Deimling, A., Eibl, R.H., Ohgaki, H., Louis, D.N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R.Y., Wiestler, O.D., and Seizinger, B.R. (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res. 52, 2987-2990.
18. Winqvist, R., Hampton, G.M., Mannermaa, A., Blanco, G., Alavaikko, M., Kiviniemi, H., Taskinen, P.J., Evans, G.A., Wright, F.A., Newsham, I., and Cavenee, W. (1995) Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res. 55, 2660-2664.